🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine whether the use of Trental and Vi...
Status
Completed
Location
University of Cincinnati
Start Date
2011-06
Trial ID
NCT01508221
According to literature reports, about 16.3%-19% of newly diagnosed NSCLC p...
Status
Unknown
Location
Chongqing University Cancer Hospital
Start Date
2021-03-01
Trial ID
NCT04905550
This open-label, multicenter, randomized phase II study will evaluate the u...
Status
Active Not Recruiting
Location
BC Cancer, Vancouver Centre
Start Date
2019-03-19
Trial ID
NCT03769103
Treatments Being Tested
This phase I/II trial studies the side effects and the best dose of stereot...
Status
Active Not Recruiting
Location
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
Start Date
2013-07-02
Trial ID
NCT01843413
Treatments Being Tested
The purpose of this phase 2 study is to assess the feasibility and efficacy...
Status
Terminated
Location
Duke University Medical Center
Start Date
2020-11-04
Trial ID
NCT04434560
Treatments Being Tested
Whole Brain Radiation Therapy (WBRT) has long been the mainstay of treatmen...
Status
Completed
Location
Gamma Knife Center Tilburg, Elisabeth-TweeSteden Hospital
Start Date
2016-02
Trial ID
NCT02953717
Treatments Being Tested
This is a non-controlled, open label, Phase II Study of ipilimumab combined...
Status
Completed
Location
CHU de Bordeaux
Start Date
2012-09
Trial ID
NCT02662725
Treatments Being Tested
This study aims to assess changes in vascular permeability in the brain tum...
Status
Completed
Location
University of Michigan Hospital
Start Date
2005-04
Trial ID
NCT02031237
This prospective, randomized, controlled, monocentric clinical phase III st...
Status
Unknown
Location
Dept. Radiation Oncology
Start Date
2021-02-01
Trial ID
NCT05160818
The purpose of this study is to determine the maximum dose of sunitinib tha...
Status
Completed
Location
University Health Network, Princess Margaret Hospital
Start Date
2009-07
Trial ID
NCT00981890
Treatments Being Tested